CN101244089A - 嗜酸乳杆菌/粪肠球菌培养基、制剂及其工艺 - Google Patents
嗜酸乳杆菌/粪肠球菌培养基、制剂及其工艺 Download PDFInfo
- Publication number
- CN101244089A CN101244089A CNA2007100376490A CN200710037649A CN101244089A CN 101244089 A CN101244089 A CN 101244089A CN A2007100376490 A CNA2007100376490 A CN A2007100376490A CN 200710037649 A CN200710037649 A CN 200710037649A CN 101244089 A CN101244089 A CN 101244089A
- Authority
- CN
- China
- Prior art keywords
- weight
- mycopowder
- culture medium
- bacillus
- streptococcus faecalis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000001963 growth medium Substances 0.000 title claims abstract description 75
- 240000001046 Lactobacillus acidophilus Species 0.000 title claims abstract description 68
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 title claims abstract description 67
- 238000002360 preparation method Methods 0.000 title claims abstract description 51
- 241000194032 Enterococcus faecalis Species 0.000 title claims description 59
- 238000000034 method Methods 0.000 title claims description 51
- 229940039695 lactobacillus acidophilus Drugs 0.000 title abstract description 4
- 229940032049 enterococcus faecalis Drugs 0.000 title description 2
- 238000000855 fermentation Methods 0.000 claims abstract description 79
- 230000004151 fermentation Effects 0.000 claims abstract description 79
- 239000000843 powder Substances 0.000 claims abstract description 54
- 238000011218 seed culture Methods 0.000 claims abstract description 53
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 61
- 239000002609 medium Substances 0.000 claims description 54
- 238000011081 inoculation Methods 0.000 claims description 45
- 235000015097 nutrients Nutrition 0.000 claims description 41
- 239000003223 protective agent Substances 0.000 claims description 41
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 40
- 229910052799 carbon Inorganic materials 0.000 claims description 40
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 40
- 239000000126 substance Substances 0.000 claims description 39
- 239000002904 solvent Substances 0.000 claims description 38
- 235000013336 milk Nutrition 0.000 claims description 31
- 210000004080 milk Anatomy 0.000 claims description 31
- 239000008267 milk Substances 0.000 claims description 30
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 claims description 29
- 229960000511 lactulose Drugs 0.000 claims description 29
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims description 20
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 20
- 239000011707 mineral Substances 0.000 claims description 20
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 20
- 229940073490 sodium glutamate Drugs 0.000 claims description 20
- 229920002472 Starch Polymers 0.000 claims description 19
- 239000008107 starch Substances 0.000 claims description 19
- 235000019698 starch Nutrition 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 18
- 238000011282 treatment Methods 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 11
- 206010010774 Constipation Diseases 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 241000186000 Bifidobacterium Species 0.000 claims description 4
- 241001608472 Bifidobacterium longum Species 0.000 abstract description 2
- 229940009291 bifidobacterium longum Drugs 0.000 abstract description 2
- 230000001580 bacterial effect Effects 0.000 abstract 2
- 241000194017 Streptococcus Species 0.000 abstract 1
- 239000002775 capsule Substances 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 206010012735 Diarrhoea Diseases 0.000 description 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 16
- 239000008103 glucose Substances 0.000 description 16
- 241000894006 Bacteria Species 0.000 description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 230000008569 process Effects 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000001888 Peptone Substances 0.000 description 12
- 108010080698 Peptones Proteins 0.000 description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 235000019319 peptone Nutrition 0.000 description 12
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 10
- 239000008101 lactose Substances 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 229910001220 stainless steel Inorganic materials 0.000 description 9
- 239000010935 stainless steel Substances 0.000 description 9
- 239000012137 tryptone Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 8
- 235000015193 tomato juice Nutrition 0.000 description 8
- 239000000084 colloidal system Substances 0.000 description 7
- 238000004108 freeze drying Methods 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- 201000009840 acute diarrhea Diseases 0.000 description 6
- 208000019902 chronic diarrheal disease Diseases 0.000 description 6
- 210000003128 head Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 5
- 235000011130 ammonium sulphate Nutrition 0.000 description 5
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000000227 grinding Methods 0.000 description 5
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 5
- 235000019796 monopotassium phosphate Nutrition 0.000 description 5
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 4
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 4
- 150000003863 ammonium salts Chemical class 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 229930182830 galactose Natural products 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000008240 homogeneous mixture Substances 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 241000305071 Enterobacterales Species 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000007781 pre-processing Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000003625 skull Anatomy 0.000 description 3
- 238000004804 winding Methods 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 241000702670 Rotavirus Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 235000021110 pickles Nutrition 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000012879 subculture medium Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 241000607534 Aeromonas Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000589875 Campylobacter jejuni Species 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011376 Crepitations Diseases 0.000 description 1
- 206010012742 Diarrhoea infectious Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 240000007263 Pinus koraiensis Species 0.000 description 1
- 235000011615 Pinus koraiensis Nutrition 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000000741 diarrhetic effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 238000011170 pharmaceutical development Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 210000004915 pus Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/225—Faecalis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
- Y10S435/854—Lactobacillus acidophilus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/885—Streptococcus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
脱脂奶粉 | 谷氨酸钠 | 异乳糖 | Vc-Na | 淀粉 |
2重量份 | 0.5重量份 | 2.5重量份 | 0.2重量份 | 1重量份 |
组分 | 处方1 | 处方2 | 处方3 | 处方4 | 处方5 |
脱脂奶粉 | 44g | 44g | 196g | 260g | 260g |
葡萄糖 | 12g | 12g | 58g | 80g | 80g |
酵母粉 | 24g | 54g | 54g | 54g | 60g |
硫酸铵 | 3g | 55g | 55g | 55g | 100g |
磷酸二氢钾 | 1g | 20g | 12g | 12g | 20g |
磷酸氢二钾 | 2g | 80g | 43g | 2g | 80g |
异乳糖 | 8g | 40g | 32g | 8g | 40g |
组分 | 处方1 | 处方2 | 处方3 | 处方4 | 处方5 |
西红柿汁 | 18g | 18g | 500g | 920g | 920g |
葡萄糖 | 6g | 6g | 60g | 100g | 100g |
酵母粉 | 2g | 43g | 43g | 43g | 80g |
胰胨 | 40g | 160g | 160g | 160g | 200g |
蛋白胨 | 4g | 60g | 36g | 4g | 60g |
乳糖 | 2g | 20g | 13g | 2g | 20g |
组分 | 处方1 | 处方2 | 处方3 | 处方4 | 处方5 |
脱脂奶粉 | 4.4kg | 4.4kg | 20kg | 26kg | 26kg |
葡萄糖 | 2kg | 2kg | 9kg | 12kg | 12kg |
酵母粉 | 2.4kg | 6.2kg | 6.2kg | 6.2kg | 6kg |
硫酸铵 | 0.2kg | 2.3kg | 2.3kg | 2.3kg | 4kg |
磷酸二氢钾 | 0.1kg | 1.1kg | 1.1kg | 0.1kg | 2kg |
磷酸氢二钾 | 0.1kg | 4kg | 2.1kg | 0.1kg | 4kg |
碳酸钙 | 0.2kg | 10kg | 5.3kg | 0.2kg | 10kg |
组分 | 处方1 | 处方2 | 处方3 | 处方4 | 处方5 |
西红柿汁 | 1.8kg | 1.8kg | 50kg | 92kg | 92kg |
葡萄糖 | 0.6kg | 0.6kg | 6kg | 10kg | 10kg |
酵母粉 | 0.2kg | 4.3kg | 4.3kg | 4.3kg | 8kg |
胰胨 | 4kg | 16kg | 16kg | 16kg | 20kg |
蛋白胨 | 0.4kg | 6kg | 3.6kg | 0.4kg | 6kg |
乳糖 | 0.2kg | 2kg | 1.3kg | 0.2kg | 2kg |
组分 | 处方1 | 处方2 | 处方3 | 处方4 | 处方5 |
奶粉 | 3kg | 3.75kg | 4.5kg | 6kg | 7.5kg |
谷氨酸钠 | 750g | 900g | 1.05kg | 1.2kg | 1.35kg |
异乳糖 | 6kg | 7.5kg | 5.25kg | 4.5kg | 2.7kg |
Vc-Na | 750g | 600g | 450g | 300g | 150g |
淀粉 | 4.5kg | 2.25kg | 3.75kg | 3kg | 3.3kg |
组分 | 处方1 | 处方2 | 处方3 | 处方4 | 处方5 |
奶粉 | 1.6kg | 2kg | 2.4kg | 3.2kg | 4kg |
谷氨酸钠 | 400g | 480g | 560g | 640g | 720g |
异乳糖 | 3.2kg | 4kg | 2.8kg | 2.4kg | 1.44kg |
Vc-Na | 400g | 320g | 240g | 160g | 80g |
淀粉 | 2.4kg | 1.2kg | 2kg | 1.6kg | 1.76kg |
组分 | 处方1 | 处方2 | 处方3 | 处方4 | 处方5 |
奶粉 | 1.6kg | 2kg | 2.4kg | 3.2kg | 4kg |
谷氨酸钠 | 400g | 480g | 560g | 640g | 720g |
异乳糖 | 3.2kg | 4kg | 2.8kg | 2.4kg | 1.44kg |
Vc-Na | 400g | 320g | 240g | 160g | 80g |
淀粉 | 2.4kg | 1.2kg | 2kg | 1.6kg | 1.76kg |
公斤数 | |
长型双歧杆菌菌粉J1-J5(≥10×108CPU/g) | 12.0kg |
嗜酸乳杆菌菌粉K1-K5(≥5.0×108CPU/g) | 6.0kg |
粪链球菌菌粉L1-L5(≥5.0×108CPU/g) | 3.0kg |
预胶化淀粉 | 52.5kg |
乳糖 | 52.5kg |
用量 | |
长型双歧杆菌菌粉J1-J5 | 9.2kg |
嗜酸乳杆菌菌粉K1-K5 | 4.0Kg |
粪链球菌菌粉L1-L5 | 2.5Kg |
空白颗粒 | 82.5Kg |
牛奶固体香精 | 0.4Kg |
柠檬固体香精 | 0.1Kg |
用量 | |
脱脂奶粉 | 70kg |
麦芽糊精 | 21kg |
异乳糖 | 14kg |
HPMC(2910)0.3% | 150g |
95%乙醇 | 25kg |
水 | 25kg |
Claims (10)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100376490A CN101244089B (zh) | 2007-02-16 | 2007-02-16 | 嗜酸乳杆菌/粪肠球菌培养基、制剂及其工艺 |
PCT/CN2008/070255 WO2008101428A1 (fr) | 2007-02-16 | 2008-02-03 | Milieu de culture pour lactobacillus acidophilus et streptococcus faecalis, composition le comprenant et son procédé de préparation |
US12/527,104 US9040037B2 (en) | 2007-02-16 | 2008-02-03 | Culture medium for Lactobacillus acidophilus and Streptococcus faecalis, composition comprising the same and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100376490A CN101244089B (zh) | 2007-02-16 | 2007-02-16 | 嗜酸乳杆菌/粪肠球菌培养基、制剂及其工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101244089A true CN101244089A (zh) | 2008-08-20 |
CN101244089B CN101244089B (zh) | 2013-09-25 |
Family
ID=39709642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100376490A Active CN101244089B (zh) | 2007-02-16 | 2007-02-16 | 嗜酸乳杆菌/粪肠球菌培养基、制剂及其工艺 |
Country Status (3)
Country | Link |
---|---|
US (1) | US9040037B2 (zh) |
CN (1) | CN101244089B (zh) |
WO (1) | WO2008101428A1 (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101792725A (zh) * | 2010-03-16 | 2010-08-04 | 辽宁大学 | 一种富集粪链球菌的培养基 |
CN102028713A (zh) * | 2010-12-12 | 2011-04-27 | 夏学德 | 一种用于降低血清胆固醇的益生菌制剂及其制备方法 |
CN103830278A (zh) * | 2012-11-21 | 2014-06-04 | 上海信谊药厂有限公司 | 活菌冻干粉以及三联活菌制剂的制备方法 |
CN106072547A (zh) * | 2016-06-28 | 2016-11-09 | 张标 | 一种具有减肥和调节肠胃功能的益生菌粉 |
WO2021170138A1 (zh) | 2020-02-27 | 2021-09-02 | 上海上药信谊药厂有限公司 | 抗肿瘤组合物 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103540550B (zh) * | 2013-10-26 | 2015-03-25 | 兰亚朝 | 乳酸粪链球菌的发酵方法 |
CN114891685B (zh) * | 2022-05-30 | 2023-04-14 | 微康益生菌(苏州)股份有限公司 | 一种提高嗜酸乳杆菌抗逆性的组合物及其制备方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4147773A (en) | 1977-12-12 | 1979-04-03 | Morinaga Milk Industry Co., Ltd. | Powdery composition comprising viable Bifidobacteria cells and lactulose |
CN1056750C (zh) * | 1993-12-10 | 2000-09-27 | 济南三株药业有限公司 | 一种营养保健口服液及其制法 |
US5843474A (en) | 1995-10-11 | 1998-12-01 | Reverse Transport Licensing & Consulting, Inc. | Method of dialysis treatment, and dialysis apparatus related thereto |
CN1119154C (zh) * | 1998-01-20 | 2003-08-27 | 上海信谊药业有限公司 | 双歧三联活菌制剂及制备方法 |
US6368591B2 (en) * | 1998-05-15 | 2002-04-09 | Shanghai Sine Pharmaceutical Corporation Ltd. | Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof |
JP2002142719A (ja) * | 2000-11-07 | 2002-05-21 | Yutaka Sanbonmatsu | 整腸栄養食品 |
JP4528472B2 (ja) | 2001-11-29 | 2010-08-18 | ビオフェルミン製薬株式会社 | 歯周病の予防または治療剤 |
-
2007
- 2007-02-16 CN CN2007100376490A patent/CN101244089B/zh active Active
-
2008
- 2008-02-03 WO PCT/CN2008/070255 patent/WO2008101428A1/zh active Application Filing
- 2008-02-03 US US12/527,104 patent/US9040037B2/en active Active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101792725A (zh) * | 2010-03-16 | 2010-08-04 | 辽宁大学 | 一种富集粪链球菌的培养基 |
CN102028713A (zh) * | 2010-12-12 | 2011-04-27 | 夏学德 | 一种用于降低血清胆固醇的益生菌制剂及其制备方法 |
CN103830278A (zh) * | 2012-11-21 | 2014-06-04 | 上海信谊药厂有限公司 | 活菌冻干粉以及三联活菌制剂的制备方法 |
CN106072547A (zh) * | 2016-06-28 | 2016-11-09 | 张标 | 一种具有减肥和调节肠胃功能的益生菌粉 |
WO2021170138A1 (zh) | 2020-02-27 | 2021-09-02 | 上海上药信谊药厂有限公司 | 抗肿瘤组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN101244089B (zh) | 2013-09-25 |
WO2008101428A1 (fr) | 2008-08-28 |
US20100119487A1 (en) | 2010-05-13 |
US9040037B2 (en) | 2015-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105054040B (zh) | 一种益生菌发酵人参的组合物及其制备方法和应用 | |
CN101244089B (zh) | 嗜酸乳杆菌/粪肠球菌培养基、制剂及其工艺 | |
CN102318806B (zh) | 一种益生菌发酵南瓜、胡萝卜蔬菜粉的制备方法 | |
CN108883127A (zh) | 用于预防和治疗***病的包含乳酸菌的组合物及其用途 | |
CN1119154C (zh) | 双歧三联活菌制剂及制备方法 | |
CN105174493B (zh) | 一种水产养殖用发酵型中草药水质改良剂的制备方法及其应用 | |
CN106617051A (zh) | 一种水果蔬菜酵素冻干粉及其制备方法 | |
CN105754876B (zh) | 一种青稞米曲、青稞米曲产品及其制备方法 | |
CN101244090B (zh) | 长型双岐杆菌培养基、制剂及其工艺 | |
CN105707625A (zh) | 一种益生菌发酵枇杷叶的组合物及其制备方法和应用 | |
CN106617090A (zh) | 苦瓜酵素及其制备方法 | |
CN107118997A (zh) | 一种饲用丁酸梭菌、促进畜禽生长的微生态制剂及其制备方法 | |
CN109069521A (zh) | 粪杆菌属细菌增殖剂 | |
CN107896921B (zh) | 玛咖和怀山药的银耳菌生物转化组合物及其制造方法 | |
CN109527308A (zh) | 一种具有调理肠胃功能的益生菌饮品及其制备方法 | |
CN108524901A (zh) | 缓解宫寒的发酵清液及其制备方法和用途 | |
CN103830278A (zh) | 活菌冻干粉以及三联活菌制剂的制备方法 | |
CN103082361A (zh) | 复合益生菌制备紫薯饮料方法 | |
CN108813255A (zh) | 发酵清液、饮品及制备方法和用途 | |
CN100577035C (zh) | 抑制轮状病毒感染的乳酸菌发酵物及其制备方法 | |
CN114949126B (zh) | 一种促进肠道有益菌增殖的中药组合物及其制备方法与应用 | |
CN109700033B (zh) | 一种调节肠道、预防便秘的益生菌组合物及其制备方法 | |
CN107753611A (zh) | 一种防癌抗癌的生物发酵组合物及其制备方法 | |
CN100359018C (zh) | 一种生物工程蛋制品及其制备方法 | |
CN117243994A (zh) | 一种防治仔猪病毒性腹泻的发酵中药复合制剂及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SHANGHAI SINE PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: SINE PHARMACEUTICAL FACTORY CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 201206 No. 905 Jinqiao Road, Shanghai Patentee after: Shanghai Sine Pharmaceutical Co., Ltd. Address before: 201206 No. 905 Jinqiao Road, Shanghai Patentee before: Sine Pharmaceutical Factory Co., Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 201206 Pudong New Area new Jinqiao Road, Shanghai, No. 905 Patentee after: Shanghai Xinyi Pharmaceutical Co. Ltd.. Address before: 201206 No. 905 Jinqiao Road, Shanghai Patentee before: Shanghai Sine Pharmaceutical Co., Ltd. |